# A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread

> **NCT04147247** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 21 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BI 905681

## Key facts

- **NCT ID:** NCT04147247
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-23
- **Primary completion:** 2021-05-06
- **Final completion:** 2021-05-27
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2023-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147247, "A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04147247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*